Millennium Development Goal 6: Combat HIV/AIDS, malaria and other diseases
Target: Achieve, by 2010, universal access to treatment for HIV/AIDS for all those who need it
Significant advances have been made in scaling-up paediatric antiretroviral treatment in the past few years, facilitated by several factors. These include integrating HIV care and treatment for children into both existing antiretroviral therapy sites focused on adult care and into maternal, newborn and child health services; reducing the prices of antiretroviral formulations for children; approving and pre-qualifying fixed-dose antiretroviral combinations for children by the United States Food and Drug Administration and the WHO Prequalification Programme; and increasing advocacy for improved access to HIV care and treatment for children.
As of December 2007, about 198,000 children under age 15 globally were receiving antiretroviral therapy, up from 127,300 in 2006 and 75,000 in 2005. This represents a 1.7-fold increase between 2006 and 2007 and a 2.6-fold increase between 2005 and 2007. The increase is occurring in every region of the world, with the most significant gains in sub-Saharan Africa. It is nonetheless evident that those children currently on treatment still represent only a small proportion of those who need it.